Document is current
Any future updates will be listed below
-
Authors
Sun, Huiling
Li, Shuo
Xu, Zhaohan
Liu, Chengfang
Gong, Pengyu
Deng, Qiwen http://orcid.org/0000-0003-4324-8009
Yan, Fuling
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct04175691 at ClinicalTrials.govDocuments that mention this clinical trial
Therapeutic application of exosomes in ischaemic stroke
https://doi.org/10.1136/svn-2020-000419
SNHG15 is a negative regulator of inflammation by mediating TRAF2 ubiquitination in stroke-induced immunosuppression
https://doi.org/10.1186/s12974-021-02372-z
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (81901215)
- License Information
-
More Information
Article History
Received: 11 October 2021
Accepted: 22 December 2021
First Online: 3 January 2022
Declarations
:
: All participants offered informed consent. The study protocol was approved by the Ethics Committee of Nanjing Medical University (No. (2019)695) and Southeast University (No. 2018ZDKYSB193), and followed the tenets of the Declaration of Helsinki.
: Not applicable.
: The authors declare that they have no competing interests.
